Trump's Cannabis Reclassification Boosts Incannex

Cannabis Stocks Surge: Trumps Reclassification Boosts Incannex HealthcarePresident Trumps executive order to reclassify marijuana as a less dangerous drug has ignited excitement in the cannabis sector, with Incannex Healthcare leading the charge. The Australian-based biopharma company saw its shares jump 22% in the past month and 86% over the last six months. Despite mixed year-to-date returns, Incannexs focus on medicinal cannabis treatments and psychedelic therapies positions it for potential growth. With trials in stage one and two, easier U.S. access could accelerate FDA approvals and unlock massive markets. Keep an eye on Incannexs trial updates for potential profits in the cannabis space.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.